Study of Quality of Life and Functional Outcomes in Adults Diagnosed With Anal Cancer

What this Trial Is About

Anal cancer is a rare but increasing disease, with about 200 new patients yearly in Sweden. This research aims to understand the quality of life and functional outcomes in patients diagnosed with anal cancer. The study focuses on identifying early side effects from treatment and long-term health issues after diagnosis and treatment. The study involves patients diagnosed with anal cancer who will be invited to participate after identification at a national tumor board. Participants will complete questionnaires about their quality of life, urinary, bowel, and sexual function at multiple time points at diagnosis, then 3, 12, 36, 60, and 120 months after diagnosis. Participants will be followed and asked to fill out these questionnaires over several years to monitor changes and outcomes related to their condition and treatment. Researchers will measure quality of life and bodily functions at 3 months, 12 months, and 3 years after diagnosis to understand treatment toxicity and long-term effects. The study may continue up to 2035, providing long-term data on patient outcomes.

ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer